miR-326 inhibits the progression of papillary thyroid carcinoma by targeting MAPK1 and ERBB4

Nie, FR; Li, QX; Wei, HF; Ma, Y

NEOPLASMA, 2020; 67 (3): 604

Abstract

Papillary thyroid carcinoma (PTC) is the prevalent histotype of thyroid cancer, with increasing incidence worldwide. MicroRNAs (miRNAs) could play an ......

Full Text Link